Filing Details
- Accession Number:
- 0001209191-22-016529
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-03-04 21:00:26
- Reporting Period:
- 2022-02-23
- Accepted Time:
- 2022-03-04 21:00:26
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1655759 | Arvinas Inc. | ARVN | Pharmaceutical Preparations (2834) | 472566120 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1753537 | G John Houston | C/O Arvinas, Inc. 5 Science Park, 395 Winchester Ave. New Haven CT 06511 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-03-04 | 17,511 | $0.00 | 849,844 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-03-04 | 6,024 | $63.94 | 843,820 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Acquisiton | 2022-02-23 | 200,500 | $0.00 | 200,500 | $64.19 |
| Common Stock | Restricted Stock Units | Disposition | 2022-03-04 | 17,511 | $0.00 | 17,511 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 200,500 | 2032-02-22 | No | 4 | A | Direct | |
| 17,510 | No | 4 | M | Direct |
Footnotes
- Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock.
- This sale was made to cover withholding taxes following the vesting of previously granted Restricted Stock Units.
- The broker sold shares of the Issuer's common stock for certain employees following the vesting of previously granted Restricted Stock Units, including the common stock reported on this Form 4 by the reporting person, at an average price of $63.94.
- This option award was granted on February 23, 2022. 1/4 of the shares underlying the award shall vest on February 23, 2023, with the remainder of the shares vesting in equal monthly installments following February 23, 2023 through February 23, 2026.
- On March 1, 2019, the reporting person was granted 70,042 Restricted Stock Units, vesting in four equal annual installments beginning March 1, 2020.
Billionaire Hedge Funds
